Article
Phenotypic implications of pathogenic variant types in Pompe disease.
Journal of human genetics - 1 Nov 2021
Viamonte Manuel A, Filipp Stephanie L, Zaidi Zara, Gurka Matthew J, Byrne Barry J, Kang Peter B
Abstract excerpt
Newborn screening and therapies for Pompe disease (glycogen storage disease type II, acid maltase deficiency) will continue to expand in the future. It is thus important to determine whether enzyme activity or type of pathogenic genetic variant in GAA can best predict phenotypic severity, particularly the presence of infantile-onset Pompe disease (IOPD) versus late-onset Pompe disease (LOPD). We performed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
